Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)

FRA:UJ9 Statistics

Total Valuation

FRA:UJ9 has a market cap or net worth of EUR 701.10 million. The enterprise value is 718.21 million.

Market Cap	701.10M
Enterprise Value	718.21M

Important Dates

The last earnings date was Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	622.33M
Shares Outstanding	n/a
Shares Change (YoY)	+11.62%
Shares Change (QoQ)	+2.09%
Owned by Insiders (%)	2.54%
Owned by Institutions (%)	1.37%
Float	198.30M

Valuation Ratios

The trailing PE ratio is 184.15 and the forward PE ratio is 41.34.

PE Ratio	184.15
Forward PE	41.34
PS Ratio	7.79
PB Ratio	2.90
P/TBV Ratio	8.77
P/FCF Ratio	134.11
P/OCF Ratio	77.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 49.31, with an EV/FCF ratio of 137.38.

EV / Earnings	188.64
EV / Sales	7.84
EV / EBITDA	49.31
EV / EBIT	92.96
EV / FCF	137.38

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.39.

Current Ratio	1.61
Quick Ratio	1.33
Debt / Equity	0.39
Debt / EBITDA	6.66
Debt / FCF	18.22
Interest Coverage	1.61

Financial Efficiency

Return on equity (ROE) is 1.87% and return on invested capital (ROIC) is 1.63%.

Return on Equity (ROE)	1.87%
Return on Assets (ROA)	1.33%
Return on Invested Capital (ROIC)	1.63%
Return on Capital Employed (ROCE)	2.51%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	760
Asset Turnover	0.25
Inventory Turnover	1.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+20.65%
50-Day Moving Average	1.20
200-Day Moving Average	1.27
Relative Strength Index (RSI)	40.63
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:UJ9 had revenue of EUR 89.95 million and earned 3.81 million in profits. Earnings per share was 0.01.

Revenue	89.95M
Gross Profit	64.50M
Operating Income	7.59M
Pretax Income	3.81M
Net Income	3.81M
EBITDA	14.19M
EBIT	7.59M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 78.44 million in cash and 95.24 million in debt, giving a net cash position of -16.80 million.

Cash & Cash Equivalents	78.44M
Total Debt	95.24M
Net Cash	-16.80M
Net Cash Per Share	n/a
Equity (Book Value)	241.66M
Book Value Per Share	0.42
Working Capital	65.06M

Cash Flow

In the last 12 months, operating cash flow was 9.07 million and capital expenditures -3.85 million, giving a free cash flow of 5.23 million.

Operating Cash Flow	9.07M
Capital Expenditures	-3.85M
Free Cash Flow	5.23M
FCF Per Share	n/a

Margins

Gross margin is 71.70%, with operating and profit margins of 8.44% and 4.23%.

Gross Margin	71.70%
Operating Margin	8.44%
Pretax Margin	4.23%
Profit Margin	4.23%
EBITDA Margin	15.78%
EBIT Margin	8.44%
FCF Margin	5.81%

Dividends & Yields

FRA:UJ9 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.62%
Shareholder Yield	-11.62%
Earnings Yield	0.54%
FCF Yield	0.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:UJ9 has an Altman Z-Score of 2.25 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.25
Piotroski F-Score	6